期刊文献+

血清炎性因子联合检测对急性冠状动脉综合征的预测价值研究 被引量:2

Prediction Value of Combined Detection of Serum Inflammatory Factors in Acute Coronary Syndrome
下载PDF
导出
摘要 目的研究血清炎性因子联合检测对急性冠状动脉综合征的预测价值。方法选择2011年7月至2013年9月海军总医院收治的稳定型心绞痛(SAP)、不稳定型心绞痛(UAP)、急性非ST段抬高型心肌梗死(NSTEMI)型、急性ST段抬高型心肌梗死(STEMI)患者及体检的健康者各40例,分别纳入研究的SAP组、UAP组、NSTEMI组、STEMI组和对照组,检测心肌酶谱指标肌酸激酶同工酶(CK-MB)、高敏心肌肌钙蛋白(hs-c Tn T)及炎性因子C反应蛋白(CRP)、基质金属蛋白酶9(MMP9)、金属蛋白酶组织抑制剂(TIMP)的水平。结果五组受试者心肌酶谱(CK-MB、hs-c Tn T)及炎性因子(CRP、MMP9、TIMP1、MMP9/TIMP1)的差异有统计学意义(P<0.05)。对照组、SAP组、UAP组、NSTEMI组、STEMI组CK-MB为(8.2±0.9)U/L,(8.5±1.1)U/L,(9.2±1.4)U/L,(29.2±4.6)U/L,(71.3±10.4)U/L;hs-c Tn T为(4.3±0.6)ng/L,(4.7±0.5)ng/L,(5.1±0.7)ng/L,(21.8±4.6)ng/L,(34.2±6.3)ng/L。SAP组、UAP组与对照组心肌酶谱比较差异无统计学意义(P>0.05),NSTEMI组、STEMI组显著高于对照组;UAP组与SAP组比较差异无统计学意义(P>0.05),NSTEMI组、STEMI组显著高于SAP组(P<0.05);NSTEMI组、STEMI组显著高于UAP组(P<0.05);STEMI组显著高于NSTEMI组(P<0.05)。对照组、SAP组、UAP组、NSTEMI组、STEMI组CRP为(5.1±0.7)mg/L,(5.3±0.6)mg/L,(11.8±2.4)mg/L,(31.2±4.2)mg/L,(55.8±6.9)mg/L;MMP9为(14.8±2.1)μg/L,(16.3±2.8)μg/L,(28.4±4.2)μg/L,(40.6±5.9)μg/L,(66.8±9.2)μg/L;TIMP1为(49.2±6.2)μg/L,(48.5±6.8)μg/L,(32.4±5.4)μg/L,(24.4±3.5)μg/L,(15.9±2.4)μg/L;MMP9/TIMP1为0.30±0.08,0.31±0.07,0.87±0.11,1.66±0.19,4.20±0.52。炎性因子:SAP组与对照组比较差异无统计学意义(P>0.05),UAP组、NSTEMI组、STEMI组显著高于对照组(P<0.05);UAP组、NSTEMI组、STEMI组显著高于SAP组(P<0.05);NSTEMI组、STEMI组显著高于UAP组(P<0.05);STEMI组显著高于NSTEMI组(P<0.05)。结论急性冠状动脉综合征患者血清中CRP、MMP9和TIMP1水平在UAP阶段即出现明显异常,联合检测是早期诊断疾病的理想指标。 Objective To study the prediction value of combined detection of serum inflammatory fac-tors in acute coronary syndrome.Methods Patients with stable angina pectoris(SAP),unstable angina pec-toris(UAP),non ST segment elevation acute myocardial infarction(NSTEMI),STsegment elevation acute myocardial infarction( STEMI) and healthy people received physical examination in PLA Navy General Hos-pital during Jul.2011 and Sep.2013 were collected and enrolled in SAP group,UAP group,NSTEMI group, STEMI group and control group.Myocardial enzymes Creatine Kinase MB ( CK-MB) ,high-sensitivity cardiac troponin T (hs-cTnT) and inflammatory factor CRP,MMP9,TIMP of the five groups were detected.Results There were significant difference in level of myocardial enzyme CK-MB, hs-cTnT and CRP, MMP9, TIMP1 and MMP9/TIMP1 among five groups(all P〈0.05), level of CK-MB of control group,SAP group, UAP group,NSTEMI group and STEMI group were(8.2 ±0.9) U/L,(8.5 ±1.1) U/L,(9.2 ±1.4) U/L, (29.2 ±4.6) U/L,(71.3 ±10.4) U/L;hs-cTnT were(4.3 ±0.6) ng/L,(4.7 ±0.5) ng/L,(5.1 ± 0.7) ng/L,(21.8 ±4.6) ng/L,(34.2 ±6.3) ng/L.CK-MB, hs-cTnT in NSTEMI and STEMI group was significantly higher than those in the control group (P〈0.05); CK-MB, hs-cTnT in NSTEMI and STEMI group were significantly higher than those in SAP group ( P 〈0.05 ); CK-MB, hs-cTnT in NSTEMI and STEMI group was significantly higher than that in UAP group (P〈0.05);CK-MB, hs-cTnT in STEMI group was significantly higher than that of NSTEMI group (P〈0.05).Level of CRP of control group,SAP group, UAP group ,NSTEMI group and STEMI group were (5.1 ±0.7) mg/L,(5.3 ±0.6) mg/L,(11.8 ±2.4) mg/L,(31.2 ±4.2) mg/L,(55.8 ±6.9) mg/L;MMP9 (14.8 ±2.1) μg/L,(16.3 ±2.8) μg/L,(28.4 ± 4.2) μg/L,(40.6 ±5.9) μg/L,(66.8 ±9.2) μg/L;TIMP1 (49.2 ±6.2) μg/L,(48.5 ±6.8) μg/L, (32.4 ±5.4) μg/L,(24.4 ±3.5) μg/L,(15.9 ±2.4) μg/L;MMP9/TIMP1 0.30 ±0.08,0.31 ±0.07, 0.87 ±0.11 ,1.66 ±0.19 ,4.20 ±0.52.Inflammatory factor in the UAP group , NSTEMI and STEMI group was significantly higher than that of control group (P〈0.05);Inflammatory factor in UAP group, NSTEMI group and STEMI group was significantly higher than that of SAP group (P〈0.05);Inflammatory factor in NSTEMI group and STEMI group was significantly higher than that in UAP group ( P〈0.05 );Inflammatory factor in STEMI group was significantly higher than that of NSTEMI group (P〈0.05).Conclusion Serum content of CRP,MMP9 and TIMP1 in acute coronary syndrome patients are obviously abnormal in the stage of UAP and combined detection is an ideal approach for early diagnosis of diseases.
出处 《医学综述》 2015年第13期2461-2463,共3页 Medical Recapitulate
关键词 急性冠状动脉综合征 炎性因子 心肌酶 基质金属蛋白酶 Acute coronary syndrome Inflammatory factor Myocardial enzyme Matrix metalloproteinase
  • 相关文献

参考文献10

  • 1李瑞杰,卢全,胡大一.美国心脏病学会/美国心脏协会ST段抬高心肌梗死治疗指南(2004年版)要点解读[J].中国循证医学杂志,2005,5(2):167-170. 被引量:5
  • 2刘成桂,彭端亮,罗俊,刘于嵩,谢国明,李扑,涂植光.联合检测MPO、IL-6和hs-CRP对冠心病危险分层的价值[J].第三军医大学学报,2011,33(19):2061-2065. 被引量:14
  • 3李如意,李秀芳,刘永欣,齐晓勇.联合检测血清炎症因子对急性冠脉综合征的预测价值[J].江苏医药,2011,37(2):190-192. 被引量:10
  • 4Cherneva ZV,Denchev SV,Gospodinova MV.Inflammatory cytokines at admission——independent prognostic markers in patients with acute coronary syndromeand hyperglycaemia[J].Acute Card Care,2012,14(1):13-19.
  • 5KubkováL,Spinar J,PávkováGoldbergováM,et al.Inflammatory response and C-reactive protein value in patient with acute coronary syndrome[J].Vnitr Lek,2013,59(11):981-988.
  • 6Abhashi SA,Kryeziu FU,Nazreku FD.Increased carotid intimamedia thickness associated with high hs-CRP levels is a predictor of unstable coronary artery disease[J].Cardiovasc J Afr,2013,24(7):270-273.
  • 7耿国英,刘恒亮,沈德良,刘洋,赵友民,郝冬琴,王贺.急性冠脉综合征患者炎症标志物的变化及意义[J].山东医药,2011,51(52):66-67. 被引量:9
  • 8Pérez-Hernández N,Ibanes-Gutiérrez C,Vargas-Alarcón G,et al.Involvement of matrix metalloproteinases in acute coronary syndrome(ACS)[J].Gac Med Mex,2013,149(6):655-667.
  • 9Chuang LP,Chen NH,Lin SW,et al.Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients[J].Life Sci,2013,93(5/6):220-225.
  • 10Dabek J,Glogowska-Ligus J,Szadorska B.Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor(TIMP-2)in acute coronary syndrome patients[J].J Postgrad Med,2013,59(2):115-120.

二级参考文献37

  • 1ZHANG Xing-wei,GE Jun-bo,YANG Jian-min,GE Lei,WANG Ning-fu,GAO Yan,LI Pei-zhang,PAN Hao,TONG Guo-xin,ZHOU Liang,YE Xian-hua,XU Jian.Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study[J].Chinese Medical Journal,2006(20):1689-1694. 被引量:23
  • 2Moreno PR. Pathophysiology of plaque disruption and thrombosis in acute isehemie syndromes[J].J Stroke Cerebrovase Dis,2001,10(2 Pt 2) :2-9.
  • 3Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree[J]. J Am Coll Cardiol,2005,45(10): 1585-1593.
  • 4Espliguero RA, Avanzas P, Sales JC, et al. C-reactive protein elevation and disease activity in patients with coronary artery disease[J]. European Heart Joumal,2004,25(5):401-408.
  • 5Konstantino Y, Nguyen TT,Wolk R, et al. Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease[J]. Biomarkrs, 2009,14(2) : 118-129.
  • 6Cheng M,Hashrnl S, Mao X,et al. Relationships of adiponeetin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome[J]. Can J Cardiol,2008,24(5) : 385-390.
  • 7Hansson G K. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16) : 1685 -1695.
  • 8Kashiwagi M, Imanishi T, Tsujioka I-I, et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris[J]. Atherosclerosis, 2010, 212(1 ) : 171 - 176.
  • 9Takada A, Saito K, Murai T, et al. Pathological evaluation of coronary lesions in cases of cardiac rupture during acute myocardial infarction: an autopsy study of 148 out-of-hospital sudden death cases[ J-. Pathol Res Pract, 2009, 205(4) : 241 -247.
  • 10Antman E M, Hand M, Armstrong P W, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Call Cardiol, 2008, 51(2) : 210 -247.

共引文献32

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部